It is not known whether it is safe to consume alcohol with Lubigut 8. Please consult your doctor.
CONSULT YOUR DOCTOR
Lubigut 8 may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
SAFE IF PRESCRIBED
Lubigut 8 is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
CONSULT YOUR DOCTOR
It is not known whether Lubigut 8 alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
SAFE IF PRESCRIBED
Lubigut 8 is safe to use in patients with kidney disease. No dose adjustment of Lubigut 8 is recommended.
CAUTION
Lubigut 8 should be used with caution in patients with liver disease. Dose adjustment of Lubigut 8 may be needed. Please consult your doctor.
Medicine Overview of Lubigut 8 8mcg Capsule
Introduction
Lubigut 8 is a prescription medicine used to treat constipation and irritable bowel syndrome (symptoms include abdominal pain, cramping, bloating, and diarrhea or constipation). It works by increasing the secretion of fluids in the intestine, thereby making the stool soft and easier to pass. Lubigut 8 is taken after meals to avoid nausea in a dose and duration as advised by the doctor. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your doctor know about all other medications...
... Show more
Uses of Lubigut 8
Constipation
Irritable bowel syndrome
Side effects of Lubigut 8
Common
Nausea
Headache
Abdominal pain
Abdominal distension
Diarrhea
Flatulence
How to use Lubigut 8
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lubigut 8 is to be taken with food.
How Lubigut 8 works
Lubigut 8 increases the secretion of fluids in the intestine, which in turn increases the motility of the intestine, thereby making the stool soft and easier to pass.
What if you forget to take Lubigut 8?
If you miss a dose of Lubigut 8, skip it and continue with your normal schedule. Do not double the dose.
Quick Tips
Lubiprostone should preferably be taken with meals to reduce symptoms of nausea.
Seek medical attention if you experience severe diarrhea, breathlessness (dyspnea) or difficulty in breathing, chest pain, tightness in chest during treatment.
You should be thoroughly examined to confirm the absence of obstruction (e.g. gall stones, hernia, Crohn's disease, diverticulitis, polyps, impacted bowel movement etc.) before starting lubiprostone treatment.
Lubiprostone is not recommended in children under 18 years of age.
Tell your doctor if you are pregnant or planning to become pregnant or are breastfeeding.
Brief Description
Indication
Irritable Bowel Syndrome with Constipation (IBS-C), Chronic idiopathic constipation, Opioid-induced Constipation (OIC) in adults with chronic non-cancer pain
Administration
Should be taken with food.
Adult Dose
Oral
Chronic idiopathic constipation
Adult: 24 mcg bid daily.
Irritable Bowel Syndrome With Constipation
8 mcg twice daily.
Opioid-Induced Constipation
Treatment in patients with chronic noncancer pain
24 mcg bid daily.
Hepatic impairment
Mild: Dose adjustment not necessary
Moderate (Child-Pugh B): Chronic idiopathic or opioid-induced constipation, 16 mcg PO q12hr; irritable bowel syndrome with constipation (IBS-C), no dosage adjustment required
Severe (Child-Pugh C): Chronic idiopathic or opioid-induced constipation, 8 mcg PO q12hr; IBS-C, 8 mcg PO q24hr
Child Dose
Safety and efficacy not established
Contraindication
History of mechanical GI obstruction.
Mode of Action
Lubiprostone is a locally acting chloride channel activator that enhances a chloride-rich intestinal fluid secretion without altering sodium and potassium concentrations in the serum. Lubiprostone acts by specifically activating ClC-2, which is a normal constituent of the apical membrane of the human intestine. By increasing intestinal fluid secretion, Lubiprostone increases motility in the intestine, thereby facilitating the passage of stool and alleviating symptoms associated with chronic idiopathic constipation.
Precaution
Safety has not been established in pregnant women. Not to be used in patients with severe diarrhoea.
Lactation: Unknown whether drug is excreted in breast milk; because lubiprostone increases fluid secretion in the intestine and intestinal motility, monitor breastfeeding infants for diarrhea